Microbiotica raised €61M in a Series B round in Mar 2022. The company is based in Cambridge, UK. Investors in the round: British Patient Capital, Cambridge Innovation Capital, Flerie Invest and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.